Day: 16 May 2022

  • What’s dragging on the Wesfarmers share price on Monday?

    a businessman in a suit tries to forge ahead but is carrying a rope attached to a large anchor that is stuck in the ground against a background of muted sky and barren earth.a businessman in a suit tries to forge ahead but is carrying a rope attached to a large anchor that is stuck in the ground against a background of muted sky and barren earth.

    The Wesfarmers Ltd (ASX: WES) share price has been rangebound on Monday and remains bottom-heavy at $49.56, down 0.81%.

    After dropping sharply from the open, Wesfarmers’ shares managed to claw back from a low of $49.36 in early trade.

    What’s up with the Wesfarmers share price?

    Whilst ASX consumer discretionary shares are generally trading higher today, Wesfarmers shares have slipped lower.

    Despite no market-sensitive updates, analysts at Citi have downgraded their recommendation on Wesfarmers from neutral to sell.

    The investment bank anticipates that Australian households will have reduced capacity to spend on domestic retail in FY22 and FY23. It predicts the sector is set to face headwinds to the tune of $68 billion and $61 billion respectively.

    It also expects “a further drag from additional interest rate increases and the resumption of normal travel activity in FY24”.

    The broker mentions both Harvey Norman and home hardware giant Bunnings throughout its review, noting the latter’s softer earnings prospects.

    It slashed its valuation on Wesfarmers by 16% to $42 per share, citing risks to “margins normalising back towards pre-COVID levels and slower revenue growth as the housing market cools”.

    Meanwhile, 25% of brokers covering the stock have Wesfarmers still rated as a buy while 50% have it rated as a hold, according to Bloomberg data.

    The remaining 25% of coverage urges its clients to sell Wesfarmers shares. The consensus price target from this list is $49.60, raising questions on whether Wesfarmers is fairly priced at its current levels.

    In the last 12 months, the Wesfarmers share price has compressed down by more than 8% after a 16% slump this year to date.

    The post What’s dragging on the Wesfarmers share price on Monday? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Wesfarmers right now?

    Before you consider Wesfarmers, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wesfarmers wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/WmH1pTa

  • Where next for the CSL share price?

    Two medical researchers in white coats collaborate over a computer screen of data in a medical research laboratory

    Two medical researchers in white coats collaborate over a computer screen of data in a medical research laboratoryThe CSL Limited (ASX: CSL) share price has started the week in the red.

    In afternoon trade, the biotherapeutics giant’s shares are down 1.5% to $276.79.

    Where next for the CSL share price?

    According to a note out of Citi, its analysts believe the CSL share price could be heading higher from here.

    The note reveals that its analysts have retained their buy rating and $335.00 price target on the company’s shares.

    Based on the current CSL share price, this implies potential upside of 21% for investors over the next 12 months.

    What is the broker saying?

    Citi has been looking at industry data and believes that it is pointing to continued improvement in plasma collections and strong underlying demand.

    It believes this supports its view that the key drivers of the CSL share price will shift in the near future to product demand and the acquisition of Vifor Pharma.

    It commented:

    The latest quarterly results from Grifols, Takeda and Haemonetics, and recent comments from CSL are all highlighting the continued improvement in plasma collection and strong underlying demand for plasma products.

    This is consistent with our view that over the next six months, we expect the market to shift its focus to the strong underlying plasma product demand, and the closure the Vifor deal, both of which should lead to strength in the share price.

    Our FY23-24 EPS estimates remain 5-6% above consensus (we have included the Vifor consensus estimates in our forecasts). The next catalyst will be the closure of the Vifor transaction which is now expected to complete by the end of Sept (previously June).

    All in all, the broker appears to see the CSL share price as trading at an attractive level for investors at present and I would have to agree due to the points outlined above.

    The post Where next for the CSL share price? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in CSL right now?

    Before you consider CSL, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/HbXv3nA

  • DGL share price surges 5% on acquisition announcement

    Male DGL employees working with chemical bins symbolising the rising DGL share price todayMale DGL employees working with chemical bins symbolising the rising DGL share price today

    The DGL Group Ltd (ASX: DGL) share price is on the move today.

    This comes after the company announced the acquisition of a chemical warehousing and distribution business.

    At the time of writing, DGL shares are up 5.36% to $2.95 apiece.

    DGL expands warehousing capacity

    According to its release, DGL advised it has strategically acquired the Temples chemicals warehousing division for $3.5 million.

    Located in Perth, Temples’ chemical storage and warehouse business in one of the largest of its type in Western Australia. The group provides store, consolidate and distributes a variety of freight types within the industry.

    The agreed purchase price represents a valuation of 2.2 times the last twelve months of Temples’ earnings (FY21). The deal is being funded solely by tapping into DGL’s existing cash reserves.

    DGL stated that Temples adds 13,000 tonnes of chemical storage capacity to its Western Australia operations.

    In addition, there is now over 10,000 square kilometres of operational space for transport equipment and shipping container work.

    This takes DGL’s total chemical storage to more than 153,000 tonnes across 56 dedicated chemical management sites.

    DGL founder and CEO, Simon Henry commented:

    The acquisition of Temples chemical warehousing division helps with our organic growth as well as targeted new business opportunities.

    DGL share price summary

    It’s been an impressive 12 months for the DGL share price, rising by more than 192% in value.

    The company entered the ASX in late May with a share price of $1 and has made quick progress since.

    Based on valuation metrics, DGL presides a market capitalisation of roughly $781.74 million, with 269.84 million shares outstanding.

    The post DGL share price surges 5% on acquisition announcement appeared first on The Motley Fool Australia.

    Should you invest $1,000 in DGL right now?

    Before you consider DGL, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and DGL wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DGL Group Limited. The Motley Fool Australia has recommended DGL Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/d90b5wN

  • Which ASX 200 mining share has the highest dividend yield in May?

    Miner holding cash which represents dividends.

    Miner holding cash which represents dividends.S&P/ASX 200 Index (ASX: XJO) mining shares, by and large, have seen their revenues soar alongside the prices of their commodities.

    While some commodities, like iron ore, have retraced from all-time highs posted mid-last year, most, including iron ore, remain well above their historic levels.

    Atop offering a welcome tailwind for their share prices, the leading ASX 200 mining shares have also returned record amounts of money to shareholders in the form of dividends.

    So, which of the miners offers the best yield this month?

    A word on dividend yields

    Before we get to the big reveal, it’s important to note that we’re discussing trailing dividend yields here. That’s the metric you’ll most commonly see quoted, rather than a forward dividend yield, which relies on forecast earnings.

    A trailing yield is, by definition, backwards-looking. It reveals the yield you would have gotten if you’d owned a company (in this case ASX 200 mining shares) before the ex-dividend date for all of the past year’s dividend payouts. And it calculates this using the current share price.

    That means when a company’s share price falls, its trailing dividend yield rises. Conversely, if its share price rises, its trailing dividend yield falls.

    Also, bear in mind that high dividend payouts are not necessarily sustainable. If any of the three ASX 200 mining shares listed below sees its revenues decline, the dividend payout will likely fall as well.

    With that said…

    Which ASX 200 mining share pays the highest yield right now?

    Flush with cash, our top three dividend payers will be familiar names to you.

    Coming in at number three is Rio Tinto Ltd (ASX: RIO). The miner pays a 10.3% dividend yield, fully franked. The Rio Tinto share price is up 4.3% year-to-date.

    Up next is the world’s second-largest miner, BHP Group Ltd (ASX: BHP). BHP pays a 10.5% dividend yield, fully franked. The BHP share price is up 6.9% so far in 2022.

    Which brings us to the ASX 200 mining share with the highest dividend yield at this time, Fortescue Metals Group Ltd (ASX: FMG). Fortescue pays a whopping 15.3% dividend yield, also fully franked. The Fortescue share price is down 3.9% year-to-date.

    Happy income investing!

    The post Which ASX 200 mining share has the highest dividend yield in May? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Fortescue right now?

    Before you consider Fortescue, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Fortescue wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/qSAHPMu

  • 2 ASX All Ordinaries shares top brokers rate as buys

    Woman on her laptop thinking to herself.Woman on her laptop thinking to herself.

    Investors looking for buying opportunities during these volatile times have two ASX shares on the All Ordinaries Index (ASX: XAO) to consider.

    These ASX companies are the latest buy-rated shares from leading brokers and both shares are outperforming today.

    The All Ordinaries share to buy for its market-beating potential

    The first is the Endeavour Group Ltd (ASX: EDV). Shares in the hospitality group have been in the green all day and are trading 2% higher at $7.74 at the time of writing. In comparison, the All Ords has gained 0.28%.

    According to JPMorgan, there’s still more room for the Endeavour share price to run. The broker initiated coverage on the shares with an ‘overweight’ recommendation and an $8.60 per share price target.

    The optimism stems from the broker’s belief that the market is underestimating the group’s earnings potential over the next few years. Said JPMorgan:

    Our EPS [earnings per share] forecasts are 5% and 6% ahead of Bloomberg consensus in FY23 and FY24, respectively, due to the reinvestment in the hotel network and continued strength in the retail drinks business.

    This price target implies a 24.6x FY24 PER, underpinned by the market-leading position of the retail and hotels business, both of which have a deep moat and earnings growth optionality, which justifies a premium to the market, in our view.

    Worth adding to your shopping list

    Meanwhile, the Universal Store Holdings Ltd (ASX: UNI) share price is also outperforming today. Shares in the fashion retailer rallied 3.5% to $4.66 at the time of writing.

    The rally coincides with Citigroup’s decision to start coverage on Universal shares with a ‘buy’ recommendation.

    The broker’s optimism is based on the view that the Universal Store share price has several medium-term growth drivers.

    These include new store rollouts and margin expansion opportunities. These drivers could see the retailer generate a 10% CAGR for its earnings per share from FY21 to FY24.

    Citigroup said:

    Universal’s store rollout target of 100+ across ANZ appears to be conservative given our analysis indicates potential for the company to roll out 110 stores.

    We forecast Universal’s EBITDA margin to expand ~100 bps over FY21 to FY25e, driven by new stores reaching maturity, increasing private brand penetration, higher levels of direct sourcing and scale benefits.

    The broker’s 12-month price target on the Universal Store share price is $5.83 a share. The retailer is also forecast to pay a 27.1 cents a share dividend in FY23.

    The post 2 ASX All Ordinaries shares top brokers rate as buys appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of January 12th 2022

    More reading

    Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/FrjVaub

  • Brokers: 2 ASX 200 shares that could be top buys for growth

    A woman sits at her computer with hand to mouth and a contemplative smile on her face although she is considering or thinking about information she is seeing on the screen.

    A woman sits at her computer with hand to mouth and a contemplative smile on her face although she is considering or thinking about information she is seeing on the screen.Brokers love finding opportunities that could make money over the long term. The two S&P/ASX 200 Index (ASX: XJO) shares in this article are leaders in their sectors and brokers have rated them as buys.

    There has been a lot of volatility in recent months, which has lowered the share prices of some of the businesses.

    Here are two ASX 200 shares that are viewed as opportunities, particularly after the declines:

    Goodman Group (ASX: GMG)

    Goodman is a large developer, owner, and manager of industrial properties around the world.

    It’s currently rated as a buy by the broker Macquarie, with a price target of $27.38. That rating came after Goodman’s FY22 third-quarter result, with the broker noting the stronger performance of the business.

    Total assets under management (AUM) increased to $68.7 billion at the end of March 2022, despite the headwind of foreign exchange rates. Its AUM is expected to grow to more than $70 billion by June 2022.

    It now has $13.4 billion of development work in progress (WIP) across 89 projects. Goodman said that it has seen 3.7% like-for-like net property income (NPI) growth in its managed partnerships.

    The ASX 200 share increased its guidance for FY22 operating earnings per security (EPS) to 23%, up from 20%.

    Goodman explained the tailwinds that are driving demand:

    Consumers continue to seek faster and more flexible delivery. This requires intensification of warehousing in urban locations, and an increase in automation and technology to optimise delivery and improve efficiency. Our global business is concentrated in key urban locations and focused on delivering opportunities through planning, change of use, sustainability features and higher intensity use. This allows our customers to achieve greater value and enhanced productivity from the space, mitigating the higher cost.

    Pinnacle Investment Management Group Ltd (ASX: PNI)

    Pinnacle is an investment platform business that aims to take investment stakes in high-quality investment managers. It can then help them grow with a number of business operations, allowing the fund manager to focus on the investing.

    Some of those services it can help with include distribution and client services, fund administration, compliance, finance, legal, technology, seed [funds under management] FUM, and so on.

    Hyperion, Plato, Solaris, Antipodes, Spheria, Firetrail, Metrics, Coolabah, and Five V are some of the investment managers it’s invested in.

    The ASX 200 share is steadily investing in areas that give exposure to new asset classes and markets.

    An important contributor to the company’s profit growth is an increase in FUM of its affiliates. In the FY22 half-year result, aggregate affiliate FUM increased 5% to $93.6 billion, while aggregate retail FUM increased 17% to $23.8 billion. This helped net profit after tax (NPAT) grow by 32% to $40.1 million.

    The company is looking to grow in North America with its 32.5% stake in Langdon equity partners. The company is based in Toronto, Canada, and it’s focused on global and Canadian small cap shares.

    The broker Macquarie also rates Pinnacle as a buy, with a price target of $11.90. That implies a possible upside of around 40% over the next year. However, the broker points out that the ASX 200 share’s FUM is expected to be hit in all of the current volatility.

    On Macquarie’s numbers, the Pinnacle share price is valued at 21 times FY22’s estimated earnings.

    The post Brokers: 2 ASX 200 shares that could be top buys for growth appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of January 12th 2022

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended PINNACLE FPO. The Motley Fool Australia has positions in and has recommended PINNACLE FPO. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/WqwEjed

  • Why the Integrated Research share price is cascading 15% today

    Rede arrow on a stock market chart going down.Rede arrow on a stock market chart going down.

    The Integrated Research Limited (ASX: IRI) share price has hitched a ride to the downside on Monday.

    At the time of writing, shares in the performance management software solutions provider are 15.4% in the red at 57.5 cents apiece. In stark contrast, the S&P/ASX 200 Index (ASX: XJO) is 0.23% better off than where it finished Friday afternoon.

    Today’s fall is yet another blow to the Integrated Research share price, taking it down 74% in the past year. The selling pressure has mounted following a disappointing downgrade in guidance, as shared in the company’s FY22 trading update.

    Setting lower expectations

    Concerned Integrated Research shareholders are selling out today as the company pulls back the curtain on performance. It appears the FY22 full year is shaping up to be a letdown compared to last year based on the latest trading update.

    While specific guidance couldn’t be given that a large portion of sales are concentrated to the end of the financial year, Integrated Research did guide compared to the previous year.

    According to the release, performance in the United States operations has not experienced the uplift that was anticipated. However, strong sales are being seen across the Asia Pacific region and the United Kingdom.

    Though, Integrated Research is now expecting subdued performance compared to the prior year. Notably, new sales have underperformed expectations as customer purchasing patterns are delayed. For reference, new sales represented 37% of total contract value (TCV) year-to-date.

    In light of this, pro-forma revenue is forecast to be down between 3% to 7% in FY22. Additionally, the company is expecting profitability to continue, but net profit after tax (NPAT) will likely be below that of last year.

    From here, the next key update is anticipated to hit the ASX in mid-July. This will follow the end of the FY22 financial year for Integrated Research.

    How does the Integrated Research share price compare?

    Currently, Integrated Research is trading on a price-to-earnings (P/E) ratio of 12.2 times. This compares to an average 29.1 times ratio for the Australian software industry.

    While it might appear ‘cheap’ on a fundamental basis, it is important to consider that the company’s earnings have been declining during the last 18 months. For example, at the end of June 2020, Integrated Research posted earnings of $24.05 million. Whereas, at the end of December 2021, this figure was down to $9.59 million.

    The Integrated Research share price is down 55% since the beginning of the year.

    The post Why the Integrated Research share price is cascading 15% today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Integrated Research right now?

    Before you consider Integrated Research, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Integrated Research wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/vAlOiPZ

  • Why Imugene, Integrated Research, Monash IVF, and Step One shares are sinking

    Red arrow going down, symbolising a falling share price.

    Red arrow going down, symbolising a falling share price.

    The S&P/ASX 200 Index (ASX: XJO) is having a reasonably positive start to the week. In afternoon trade, the benchmark index is up 0.35% to 7,100 points.

    Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are dropping:

    Imugene Limited (ASX: IMU)

    The Imugene share price has continued its slide and is down a further 6% to 16.5 cents. This means that the biotech company’s shares are now down over 60% since the start of the year. Valuation concerns have been weighing on its shares. There may also be fears that this trend could continue given its market capitalisation of almost $1 billion and no revenue.

    Integrated Research Limited (ASX: IRI)

    The Integrated Research share price has sunk 15% to 57.5 cents. This morning the global provider of user experience and performance management solutions revealed that trading conditions have been tough. As a result, it no longer expects to deliver profit growth in FY 2022.

    Monash IVF Group Ltd (ASX: MVF)

    The Monash IVF share price is down a further 5% to $1.01. This fertility treatment company’s shares have now fallen 14% since the release of a disappointing trading update last week. That update revealed that the current environment has negatively impacted stimulated cycle activity and profitability between January to April as patients defer treatment.

    Step One Clothing Ltd (ASX: STP)

    The Step One share price has crashed 55% to 21.5 cents. Investors have been selling this underwear retailer’s shares after it revealed that its expansion into the UK, US, and women’s markets hasn’t gone to plan. As a result, it expects to fall well short of its earnings guidance in FY 2022. This appears to have led to investors doubting that Step One has what it takes to successfully expand outside Australia. The company’s shares are now down 86% from its November IPO price of $1.53.

    The post Why Imugene, Integrated Research, Monash IVF, and Step One shares are sinking appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of January 12th 2022

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/UJE2oXS

  • Woodside share price lifts despite Twiggy’s latest ‘greenwashing’ accusations

    Close up of a miner wearing a hard hat with a solemn look on his face, with an oil drill in the background.Close up of a miner wearing a hard hat with a solemn look on his face, with an oil drill in the background.

    The Woodside Petroleum Limited (ASX: WPL) share price is on a roller coaster ride today.

    The energy giant’s share price leapt 1.48% in earlier trade before pulling back. Woodside shares are currently trading at $30.51, a 0.36% gain.

    Let’s take a look at what is happening at Woodside.

    Oil prices rocky

    Woodside shares have been up and down but they are not alone in this trend. The Santos Ltd (ASX: STO) share price also climbed 1.25% in morning trade before retreating. Santos shares are currently down 0.31%, trading at $8.075. For perspective, the S&P/ASX 200 Energy Index (ASX: XEJ) is up 0.39% at the time of writing but gained 1.27% in earlier trade.

    Oil prices leapt by 4% in global markets on Friday, however, they have since plunged in Asian markets. Market Risk Advisory partner Naohiro Niimura told Reuters investors “scooped up profit after a sharp gain last Friday”. He added:

    Still, with a planned ban by the EU on Russian oil and slow increase in OPEC output, oil prices are expected to stay close to the current levels near $110 a barrel until they head lower late this year due to weakening global demand

    Brent Crude oil is now down 1.82% to US$109.52 a barrel, while WTI Crude Oil is sliding 1.68% at US $108.63 a barrel, Bloomberg data shows.

    Twiggy digs in

    In other news today, Fortescue Metals Group Limited (ASX: FMG) chair Andrew ‘Twiggy’ Forrest has levelled criticism at the oil industry’s green credentials. Woodside, along with Santos, is a major ASX oil producer. Speaking ahead of an Australian Petroleum Production and Exploration conference in Brisbane, Dr Forrest told The Australian:

    I’m asking for the fossil fuel sector to say we’re supplying dirty fuel while we have to. And we’re moving as quickly as we can to change to zero pollution fuel. And don’t try and greenwash your current pollution out of existence.

    What I’m asking every fossil fuel company to do is give consumers like us green choices as soon as you possibly can. And don’t masquerade, don’t put lipstick on a pig, in the meantime.

    The post Woodside share price lifts despite Twiggy’s latest ‘greenwashing’ accusations appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Woodside Petroleum right now?

    Before you consider Woodside Petroleum, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Woodside Petroleum wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/r4KIv7Q

  • Here are the 3 most heavily traded ASX 200 shares on Monday

    blue arrows representing a rising share price ASX 200

    blue arrows representing a rising share price ASX 200

    The S&P/ASX 200 Index (ASX: XJO) is continuing to claw back ground as we open for another trading week so far this Monday. After the heavy selloff of most of last week, the ASX 200 is continuing to build on the momentum of last Friday’s session and is currently up another 0.3% to just under 7,100 points at the time of writing.

    But let’s dive a little deeper into these share market moves and take a look at the ASX 200 shares currently at the top of the market’s trading volume charts, according to investing.com.

    The 3 most traded ASX 200 shares by volume this Monday

    Qube Holdings Ltd (ASX: QUB)

    Infrastructure and logistics company Qube is our first ASX 200 share to check out today. So far this Monday, a solid 14.77 million Qube shares have been bounced around the ASX boards. This comes after a major announcement from the company this morning.

    According to an ASX release put out before market open, Qube has just completed its $400 million off-market share buyback program. The program was so popular that the company had to scale it back. Perhaps in response to this announcement, Qube shares are rocketing almost 6% today and are now going for $2.94 each. It’s probably this combination that we can thank for this elevated trading volume we see.

    Pilbara Minerals Ltd (ASX: PLS)

    ASX 200 lithium stock Pilbara is our next cab off the rank today. As it currently stands, a hefty 17.01 million Pilbara shares have traded hands on the markets this Monday. There’s no news out of Pilbara so far today, or indeed over May thus far. In saying that, Pilbarra shares are continuing to surge higher. They are up another 4.86% so far today to $2.59 at the present time. It’s this sharp appreciation that has probably sparked these higher levels of trading.

    Paladin Energy Ltd (ASX: PDN)

    Paladin Energy is our final and most traded share of the day right now. This Monday has seen a sizeable 21.27 million of this ASX 200 uranium company’s shares bought and sold thus far. Again, we have no news out of Paladin. But we have had some significant volatility today. Paladin shares initially rocketed after open, rising as high as 70 cents. However, sentiment seems to have cooled somewhat, and the company is now back in the red, going for 66 cents right now, down 0.75% for the day. It’s this whipsawing that has probably gotten Paladin to where it is on this list.

    The post Here are the 3 most heavily traded ASX 200 shares on Monday appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of January 12th 2022

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    from The Motley Fool Australia https://ift.tt/qAVJOuw